Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth

PR Newswire August 14, 2023

MediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results

PR Newswire August 10, 2023

MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status

PR Newswire August 1, 2023

MediPharm Labs Announces Change of Auditor

PR Newswire June 22, 2023

MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDA

Canada NewsWire May 15, 2023

MediPharm Labs Sets Date to Report First Quarter 2023 Financial Results

Canada NewsWire May 10, 2023

MediPharm Labs Provides Update on VIVO Integration and Board Appointee

Canada NewsWire April 13, 2023

MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership Ratio

Canada NewsWire April 3, 2023

MediPharm Labs Reports Fourth Quarter and Full Year 2022 Results

Canada NewsWire March 31, 2023

MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results

Canada NewsWire March 28, 2023

MediPharm Labs Corp. Announces Voting Results From Special Meeting of Shareholders

Canada NewsWire March 21, 2023

IIROC Trading Halt - LABS.WT

Canada NewsWire March 6, 2023

MediPharm Labs Provides Update on Clinical Trial Progress Including FDA Approval of Partner Study

PR Newswire March 1, 2023

MediPharm Labs Corp. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with VIVO Cannabis Inc.

Canada NewsWire February 21, 2023

MediPharm Labs (TSX:LABS) to acquire VIVO Cannabis (TSX:VIVO)

Caroline Egan  December 22, 2022

IIROC Trade Resumption - LABS

Canada NewsWire December 22, 2022

MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.

Canada NewsWire December 22, 2022

IIROC Trading Halt - LABS

Canada NewsWire December 22, 2022

MediPharm Labs Receives Award for CBD Brand of the Year

PR Newswire December 8, 2022

MediPharm Labs Reports Third Quarter Results

PR Newswire November 14, 2022